Interestingly, transdermal administration of NPRA siRNA nanoparticles significantly reduced eosinophilia, lung histopathology, pro-inflammatory cytokines IL-4 and IL-5, and AHR in an OVA-induced mouse asthma model [87]. Here, AHR is linked to Increased total eosinophil count.